Friday, October 23, 2026

AI Narrative Switched, Debt Yields Spike | The Weekly Wrap

CoreWeave’s rising debt yields and fading confidence in AI data-center economics frame a weekly review of Meta, Tesla, SpaceX, Netflix, French bonds and housing.

CRWV $30B

Steve Eisman Oct 23 28 clicks

Oct 23 CRWV $30B

Our Views on CoreWeave

WHAT ARE WE DOING? “Contrarians At The Gate” 12 clicks

Oct 23 BE $56B

Bloom Energy (NYSE: BE) Q3 FY12/26 Earnings - Revenue Up 138% On The Datacenter Power Race

Cestrian Capital Research 8 clicks

From X

@TidefallCapital Oct 23

Trevor Scott on X

$APP Past 5 year insider transactions: Sales: $15,825,097,564 Buys: $0 https://t.co/mIgIStK0yO

@kevin__mak Oct 23 3 clicks

Kevin Mak on X

$ABVX Couple things I noted today. 1) The ABVX fans love to talk about how bad this specific stock is. But looking at a group of late-stage, pre-commercial biotech peers since August 20th, the weakness looks a lot less ABVX-specific. ABVX is down ~26%, versus a peer median of ~27%. Different stories and catalysts, but ABVX is right in the middle of the group. 2) The latest Markit securities-lending update shows a sharp drop in reported shares on loan, from ~2.6m to ~460k. My read is that this is consistent with the possible “large short” I previously flagged having covered. The drop shows up in the October 21 data, immediately after the October 20 +5.8% rally, which has since largely fizzled out. Disclosure: Creek Drive and its affiliated funds holds a long position in ABVX. Views expressed are current opinions for information only, subject to change and are not investment advice or a recommendation to buy or sell any security. Investing involves the risk of loss and past performance is not indicative of future performance. See the disclosures link in my bio for more important information.

@BarbarianCap Oct 23 2 clicks

Barbarian Capital on X

LKQ Ousts CEO, Warns of Third-Quarter Shortfall $LKQ https://t.co/e4GW6GlTN0

@BarbarianCap Oct 23

Barbarian Capital on X

Moderna’s Cancer Vaccine Success Doesn’t Live Up to Early Hype $MRNA https://t.co/rpuprTlXsY

@BarbarianCap Oct 23

Barbarian Capital on X

"a price that is more than double that of competitor VantageScore 4.0" FICO Holds $10 Pricing for Mortgage Lenders Amid New Competition $FICO https://t.co/kyjJl8RsJj

@RagingVentures Oct 23

Raging Capital Ventures on X

$ASTS market cap today: $16 billion https://t.co/TVBwjYUiu6

@gnoble79 Oct 23

George Noble on X

Thanks my friend. $CRWV is also a zero. https://t.co/U7PIMg8X3k

@absreturnchaser Oct 23 4 clicks

absreturnchaser on X

Is Western Union $WU shopping a takeover offer they have received? @jfineman @laurenthomas @mroliverbarnes @DNair5 @bharringtonw11

Philip Morris: Taking the Fight to the U.S.

Philip Morris reported Q3 growth across heated tobacco, combustibles and e-vapor in Europe while gaining U.S. nicotine-pouch share.

PM $314B

Librarian Capital's Research Library Oct 23 2 clicks

Capital Wars

CoreWeave’s $35 billion to $39 billion 2026 spending plan relies on debt as unsecured yields reach 15%, making its GPU cloud expansion a…

CRWV $30B

Net Interest Oct 23 11 clicks

Spotify 3Q’26: Built for the Background

Spotify's third-quarter results met or exceeded guidance, with 306 million Premium subscribers and €672 million operating income, while…

SPOT $108B

MBI Deep Dives Oct 23 3 clicks

TSOH Weekly Roundup (10/23/2026)

TSOH Weekly Roundup covers Ally’s improving credit and capital returns, Pepsi’s weak beverage brands, and Match Group’s plan to revive…

ALLY $12BMTCH $11B

TSOH Investment Research Oct 23 4 clicks

Texas Instruments (NASDAQ: TXN) Stock Rating: HOLD After Q3 FY12/26 Earnings

Texas Instruments reported Q3 revenue of $6.06 billion, up 28%, with 47% operating margin and Q4 guidance above seasonal norms; Cestrian…

TXN $260B

Cestrian Capital Research Oct 23 6 clicks

Tempus AI: Moderna's New Cancer Vaccine Partner Is The Pick Of The AI Biotech Bunch

TEM $11BMRNA $98B

Edmund Ingham Oct 23 4 clicks

Putting bear cases to rest

Medpace authorized $1 billion of buybacks through 2028 after Q3 revenue rose 8.5% to $716 million; service revenue grew roughly 12% as…

MEDP $18B

Best Anchor Stocks Oct 23 14 clicks

Lockheed Martin Q3 FY12/26 Earnings Review

Lockheed Martin's Q3 missile sales rose 24% on PAC-3, THAAD, GMLRS and PrSM ramps, lifting Missiles and Fire Control backlog to $142.5…

LMT $140B

Cestrian Capital Research Oct 23 5 clicks

Industry Primers Podcast: Natural Resources Royalty & Streaming, Part One: The Story

Franco-Nevada, Wheaton and Texas Pacific Land built royalty and streaming businesses by buying fixed shares of mines and wells, tracing the…

FNV $47BWPM $57B

Latticework by MOI Global Oct 23 4 clicks

Oscar Health: Up Over 200% From The March Lows, Still Room To Run (Ticker: OSCR)

Oscar Health raised 2026 operating earnings guidance to $600 million-$800 million after ACA-marketplace expansion drove 60% membership and…

OSCR $10B

Emerging Moats Research Oct 23 4 clicks

GLXY · long

Galaxy Digital INC

Galaxy Digital (GLXY) is presented as a long investment idea.

GLXY $6B

Value Investors Club May 20 2 clicks

DoorDash: Undervalued Giant With 2x Potential!

DoorDash is framed as an undervalued giant with potential to double.

DASH $73B

Capitalist Letters May 17

Quality Trap or Buying Opportunities? IBP and MTD Updates

Installed Building Products and Mettler-Toledo, down 38% and 32%, test whether lower valuations reflect deteriorating moats or cyclical…

IBP $5.2BMTD $34B

Flyover Stocks May 16

Transocean / Valaris Merger: DOJ's Second Request, Is it a Bust?

Transocean's acquisition of Valaris faces a DOJ second request, putting the offshore-drilling merger's antitrust approval and closing…

RIG $7.2BVAL $6.8B

Open Insights May 15

MercadoLibre: The Amazon of the Amazon

MercadoLibre combines Latin American e-commerce, proprietary logistics and Mercado Pago’s payments data to build a consumer lending…

MELI $93B

Bearstone May 15

Grab Q1'26: Profitable Growth, Reasonable Valuation

Grab reported Q1 2026 operating leverage, targeted financial-services breakeven by H2 and held $5 billion cash while advertising average…

GRAB $12B

Sleep Well Investments May 15

Ferrari: The Business That Grows by Selling Less Than It Could

Ferrari sustains pricing power by limiting production, controlling distribution and protecting resale values, turning buyers into repeat…

RACE $69B

Ezra's Notes May 14

Decoding Success: Jeremy Raper – The Cost of Being Right [Part 4]

Jeremy Raper’s 2017 Sharp and Japan Display shorts bet OLED disruption would puncture inflated LCD valuations; his 2019 NIO short lost…

NIO $8.3B

Iggy on Investing Newsletter May 13

Updates on Natural Resource Partners, Cencora, and McKesson

Natural Resource Partners invested $39.2 million in Sisecam Wyoming as soda ash prices fell below production costs, helping cut the JV’s…

COR $63BMCK $118B

Eagle Point Capital May 9

OXY's Q1: The Good, The Bad, and The Pretty

Occidental Petroleum’s Q1 2026 execution and operating outperformance were offset by a costly management derivative misstep.

OXY $62B

Open Insights May 8

Friday, October 23, 2026

Trevor Scott on X

Kevin Mak on X

Barbarian Capital on X

Barbarian Capital on X

Barbarian Capital on X

Raging Capital Ventures on X

George Noble on X

absreturnchaser on X

Investor Letters

Publications we follow

Newsletters 108

YouTube 4

Blogs 15

Seeking Alpha 62 of 253

X accounts we follow

Investor letters we follow

Sectors